Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Thyroid Potency Calculations

Author(s):  Stack Bob

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Page(s):  306-309

Thyroid Potency Calculations Page 1
Thyroid Potency Calculations Page 2
Thyroid Potency Calculations Page 3
Thyroid Potency Calculations Page 4

Download in electronic PDF format for $75

Abstract:  The United States Pharmacopeia defines the label strength for Levothyroxine Sodium USP, Liothyronine Sodium USP, and Thyroid Powder USP. These powders need a certificate of analysis for potency calculations. This article is an explanation of the calculations involved to achieve the correct United States Pharmacopeia label strength for thyroid hormones.

Related Keywords: Bob Stack, RPh, thyroid hormones T4 T3, levothyroxine sodium, liothyronine sodium, certificates of analysis, thyroid USP, potency analysis

Related Categories: QUALITY CONTROL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Thyroid Potency Calculations
Stack Bob
Jul/Aug 2010
Pg. 306-309

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Snyder Scott
, Listecki Robert E
Sep/Oct 2012
Pg. 376-380

Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 545

Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 547

Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 548

Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
Nov/Dec 2008
Pg. 546

The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
Jan/Feb 2023
Pg. 22-23

Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement
Milner Martin
Jul/Aug 2005
Pg. 268-273

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina
, Garcia Lea
Jan/Feb 2001
Pg. 52-54

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina
, Garcia Lea
Nov/Dec 2000
Pg. 421-422

Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
Jan/Feb 2017
Pg. 39-45

Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 247

Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 505

Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis?
Zolner William J
May/Jun 2012
Pg. 226-229

Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding
Mar/Apr 2001
Pg. 147

Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff
, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Sep/Oct 2015
Pg. 414-419

Wilson's Syndrome and T3 Therapy
Milner Martin
Sep/Oct 1999
Pg. 344-348

The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
May/Jun 2010
Pg. 193-199

Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
Jan/Feb 2011
Pg. 56-61

Return to Top